Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guolin Tan

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Cancers|February 11, 2023
LncRNA NR120519 Blocks KRT17 to Promote Cell Proliferation and Migration in Hypopharyngeal Squamous CarcinomaZheng Zhou, Gehou Zhang, Tieqi Li, et al.
Pulmonary Therapy|August 14, 2023
A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic RhinitisBing Zhou, Lei Cheng, Jing Pan, et al.
Pulmonary Therapy|December 15, 2023
Correction: A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic RhinitisBing Zhou, Lei Cheng, Jing Pan, et al.
International Immunopharmacology|September 5, 2025
Efficacy and safety of intranasal corticosteroids combined with mucoactive drugs for chronic rhinosinusitisLi Hu, Houyong Li, Lu Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2013
Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomasYa Cao, Lifang Yang, Wuzhong Jiang, et al.
Cell Death & Disease|March 10, 2017
The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cellsYouxiang Hou, Qianling Zhu, Zheng Li, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 6, 2020
Bencycloquidium bromide nasal spray is effective and safe for persistent allergic rhinitis: a phase III, multicenter, randomized, double-blinded, placebo-controlled clinical trialZihan Jiang, Hao Xiao, Shixi Liu, et al.
The World Allergy Organization Journal|January 19, 2026
Distinct treatment response trajectories to allergen immunotherapy in allergic asthma and rhinitis: Insights from a multicenter study in routine clinical practicePingan Zhang, Rundong Qin, Weixi Zhang, et al.
Eclinicalmedicine|July 24, 2023
Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trialYuan Zhang, Bing Yan, Shen Shen, et al.
Asia Pacific Allergy|March 7, 2025
Efficacy and safety of azelastine hydrochloride and fluticasone propionate nasal spray in treating allergic rhinitis: A randomized controlled trialXinling Han, Chengshuo Wang, Qinna Zhang, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Cancers|February 11, 2023
LncRNA NR120519 Blocks KRT17 to Promote Cell Proliferation and Migration in Hypopharyngeal Squamous CarcinomaZheng Zhou, Gehou Zhang, Tieqi Li, et al.
Pulmonary Therapy|August 14, 2023
A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic RhinitisBing Zhou, Lei Cheng, Jing Pan, et al.
Pulmonary Therapy|December 15, 2023
Correction: A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic RhinitisBing Zhou, Lei Cheng, Jing Pan, et al.
International Immunopharmacology|September 5, 2025
Efficacy and safety of intranasal corticosteroids combined with mucoactive drugs for chronic rhinosinusitisLi Hu, Houyong Li, Lu Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2013
Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomasYa Cao, Lifang Yang, Wuzhong Jiang, et al.
Cell Death & Disease|March 10, 2017
The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cellsYouxiang Hou, Qianling Zhu, Zheng Li, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 6, 2020
Bencycloquidium bromide nasal spray is effective and safe for persistent allergic rhinitis: a phase III, multicenter, randomized, double-blinded, placebo-controlled clinical trialZihan Jiang, Hao Xiao, Shixi Liu, et al.
The World Allergy Organization Journal|January 19, 2026
Distinct treatment response trajectories to allergen immunotherapy in allergic asthma and rhinitis: Insights from a multicenter study in routine clinical practicePingan Zhang, Rundong Qin, Weixi Zhang, et al.
Eclinicalmedicine|July 24, 2023
Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trialYuan Zhang, Bing Yan, Shen Shen, et al.
Asia Pacific Allergy|March 7, 2025
Efficacy and safety of azelastine hydrochloride and fluticasone propionate nasal spray in treating allergic rhinitis: A randomized controlled trialXinling Han, Chengshuo Wang, Qinna Zhang, et al.
Pageof 11